http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107432860-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
filingDate 2016-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-107432860-B
titleOfInvention Preparation method of levo-oxiracetam freeze-dried powder
abstract The invention discloses a preparation method of levo-oxiracetam freeze-dried powder; the levo-oxiracetam freeze-dried powder contains the following raw and auxiliary materials in percentage by weight: 50% -59% of levo-oxiracetam, 20% -25% of L-serine, 10% -17% of mannitol, 5% -7% of sodium glutamate, 5% -10% of sodium bisulfite and 0.1% -0.5% of phenol; the levo-oxiracetam freeze-dried powder is prepared by the steps of concentrated preparation, diluted preparation, freeze drying and capping. The invention utilizes the specific excipient combination and is matched with the specific freeze-drying technology, so that the prepared levo-oxiracetam freeze-dried powder has a fixed shape, the phenomenon of bottle spraying is avoided in the freeze-drying process, the product uniformity is good, the upper layer and the lower layer are consistent in character, the antibacterial property is strong, the product is qualified through sterile inspection, the product stability is good, and the insoluble particles are obviously reduced.
priorityDate 2016-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448616730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23677676
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474448
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86748263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453191999
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID996
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558616
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5951
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18461115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414031055
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4626
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505649
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493130
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450648135
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635

Total number of triples: 50.